Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes

The incidence and prevalence of diabetes are increasing worldwide, and cardiovascular disease (CVD) is the leading cause of death among subjects with type 2 diabetes (T2D). The assessment and stratification of cardiovascular risk in subjects with T2D is a challenge. Advanced glycation end products a...

Descripción completa

Detalles Bibliográficos
Autores principales: Planas, Alejandra, Simó-Servat, Olga, Hernández, Cristina, Simó, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181586/
https://www.ncbi.nlm.nih.gov/pubmed/35682915
http://dx.doi.org/10.3390/ijms23116234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181586/
https://www.ncbi.nlm.nih.gov/pubmed/35682915
http://dx.doi.org/10.3390/ijms23116234

Ejemplares similares